Safety of tissue plasminogen activator factor in an acute stroke patient with two unruptured cerebral aneurysms

References

1. ↵
   1. Haji F,
   2. van Adel B,
   3. Avery M,
   4. Megyesi J,
   5. Young GB

   (2014) Intracranial aneurysm rupture following intravenous thrombolysis for stroke. Can J Neurol Sci 41, 95–98.
2. ↵
   1. Mittal MK,
   2. Seet RC,
   3. Zhang Y,
   4. Brown RD Jr.,
   5. Rabinstein AA

   (2013) Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms. J Stroke Cerebrovasc Dis 22, 639–643.
3. ↵
   1. Edwards NJ,
   2. Kamel H,
   3. Josephson SA

   (2012) The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms:a case series and review of the literature. italic>Stroke 43, 412–416.
4. ↵
   1. Wang HF,
   2. Chan CW,
   3. Chan HH,
   4. Hung HC

   (2013) Asymptomatic cerebral aneurysm in stroke patients eligible for intravenous thrombolytic therapy. Acta Neurol Taiwan 22, 43–48.
5. ↵
   1. Lagares A,
   2. Gómez PA,
   3. Lobato RD,
   4. Alén JF,
   5. Campollo J,
   6. Benito-León J

   (1999) Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction. Surg Neurol 52, 623–626.
6. ↵
   1. D'Olhaberriague L,
   2. Joshi N,
   3. Chaturvedi S,
   4. Mitsias P,
   5. Coplin W,
   6. Lewandowski CA,
   7. et al.

   (2000) Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms. J Stroke Cerebrovasc Dis 9, 181–184.
7. ↵
   1. Rammos SK,
   2. Neils DM,
   3. Fraser K,
   4. Klopfenstein JD

   (2012) Anterior communicating artery aneurysm rupture after intravenous thrombolysis for acute middle cerebral artery thromboembolism:case report. Neurosurgery 70, 1603–1607.
8. ↵
   1. Kane I,
   2. Sandercock P,
   3. Thomas B

   (2005) Can patients with unruptured intracranial aneurysms be treated with thrombolysis?Cerebrovasc Dis, 20, 51–52.
9. ↵
   1. Demaerschalk BM,
   2. Kleindorfer DO,
   3. Adeoye OM,
   4. Demchuk AM,
   5. Fugate JE,
   6. Grotta JC,
   7. et al.

   (2016) Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke:A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 47, 581–641.